Relief Therapeutics Holding AG Total Liabilities
Relief Therapeutics Holding AG total liabilities. Based on the latest financial reports, Relief Therapeutics Holding AG (RLF) has total liabilities worth CHF15.35 Million CHF (≈ $19.41 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Relief Therapeutics Holding AG (RLF) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Relief Therapeutics Holding AG (2006–2024)
Total liabilities of Relief Therapeutics Holding AG from 2006 to 2024. This chart illustrates how Relief Therapeutics Holding AG's total liabilities have evolved over time, based on quarterly financial data.
Relief Therapeutics Holding AG Competitors by Total Liabilities
The table below lists competitors of Relief Therapeutics Holding AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Coventry Group Ltd
AU:CYG
|
Australia | AU$205.48 Million |
|
Ariana Resources Plc
AU:AA2
|
Australia | AU$2.48 Million |
|
Eternal Energy Public Company Limited
BK:EE
|
Thailand | ฿65.08 Million |
|
Hojeon Ltd
KO:111110
|
Korea | ₩295.10 Billion |
|
Doganlar Mobilya Grubu Imalat Sanayi ve Ticaret AS
IS:DGNMO
|
Turkey | TL12.58 Billion |
|
GFG Resources Inc
V:GFG
|
Canada | CA$2.70 Million |
|
Unisync Corp
TO:UNI
|
Canada | CA$64.78 Million |
|
Globetronics Tech Bhd
KLSE:7022
|
Malaysia | RM23.70 Million |
Liability Composition Analysis (2006–2024)
This chart breaks down Relief Therapeutics Holding AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Relief Therapeutics Holding AG.
Liquidity & Leverage Metrics
Relief Therapeutics Holding AG Total Liabilities Ratios Explained
Relief Therapeutics Holding AG total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Relief Therapeutics Holding AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Relief Therapeutics Holding AG (2006–2024)
The table below shows the annual total liabilities of Relief Therapeutics Holding AG from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CHF16.56 Million ≈ $20.94 Million |
-31.46% |
| 2023-12-31 | CHF24.16 Million ≈ $30.55 Million |
-44.30% |
| 2022-12-31 | CHF43.38 Million ≈ $54.85 Million |
-38.10% |
| 2021-12-31 | CHF70.09 Million ≈ $88.61 Million |
+537.05% |
| 2020-12-31 | CHF11.00 Million ≈ $13.91 Million |
+97.70% |
| 2019-12-31 | CHF5.57 Million ≈ $7.04 Million |
-61.06% |
| 2018-12-31 | CHF14.29 Million ≈ $18.07 Million |
+42.56% |
| 2017-12-31 | CHF10.03 Million ≈ $12.68 Million |
+9.13% |
| 2016-12-31 | CHF9.19 Million ≈ $11.61 Million |
-26.36% |
| 2015-12-31 | CHF12.48 Million ≈ $15.77 Million |
-18.31% |
| 2014-12-31 | CHF15.27 Million ≈ $19.31 Million |
-39.79% |
| 2013-12-31 | CHF25.37 Million ≈ $32.07 Million |
+538.33% |
| 2012-12-31 | CHF3.97 Million ≈ $5.02 Million |
+41.26% |
| 2011-12-31 | CHF2.81 Million ≈ $3.56 Million |
-52.54% |
| 2010-12-31 | CHF5.93 Million ≈ $7.49 Million |
-30.15% |
| 2009-12-31 | CHF8.49 Million ≈ $10.73 Million |
+9.84% |
| 2008-12-31 | CHF7.73 Million ≈ $9.77 Million |
-47.21% |
| 2007-12-31 | CHF14.63 Million ≈ $18.50 Million |
+37.67% |
| 2006-12-31 | CHF10.63 Million ≈ $13.44 Million |
-- |
About Relief Therapeutics Holding AG
Relief Therapeutics Holding SA, a biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases. The company offers SETOFILM/ONDISSOLVE for nausea and vomiting associated with radiotherapy-induced, chemotherapy, and postoperative sequels; ACER-001, a sodium ph… Read more